Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Schizophrenia
Interventions
DRUG

memantine HCl

Trial Locations (13)

10962

Nathan Kline Institute, Orangeburg

20850

CBH Health, LLC, Rockville

27509

Duke University John Umstead Hospital, Butner

33136

University of Miami Jackson Memorial Hospital, Miami

52242

University of Iowa Psychiatric Research, Iowa City

63112

Metropolitan Psychiatric Center, St Louis

75062

University Hills Clinical Research, Irving

78207

Medication Research Clinic, San Antonio

91950

Synergy Clinical Research, National City

92161

VA San Diego Healthcare System, San Diego

03755

Dartmouth Hitchcock Medical School, Lebanon

27699-3601

UNC - Chapel Hill, Clinical Research Unit, Raleigh

45267-0559

University of Cincinnati Medical Science Building, Cincinnati

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY